(VIANEWS) – Southwest Airlines (LUV), DXP Enterprises (DXPE), Surgery Partners (SGRY) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Southwest Airlines (LUV)

35.4% sales growth and 5.98% return on equity

Southwest Airlines Co. is a passenger airline which provides scheduled air transport services within the United States as well as in near-international markets.

Southwest Airlines’s sales growth this year is expected to be 51.6% and 9.4% for next year.

Year-on-year quarterly revenue growth grew by 128.8%, now sitting on 18.43B for the twelve trailing months.

Volume

Today’s last reported volume for Southwest Airlines is 2875740 which is 50.13% below its average volume of 5767540.

Southwest Airlines’s sales growth for the next quarter is 35.4%. The company’s growth estimates for the ongoing quarter and the next is 405.7% and 508.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.98%.

Volatility

Southwest Airlines’s last day, last week, and last month’s current intraday variation average was 0.05%, 1.23%, and 1.81%, respectively.

Southwest Airlines’s highest amplitude of average volatility was 1.75% (day), 2.36% (last week), and 2.93% (last month), respectively.

Southwest Airlines’s Stock Yearly Top and Bottom Value

Southwest Airlines’s stock is valued at $39.24 at 20:22 EST, way below its 52-week high of $56.33 and way higher than its 52-week low of $34.36.

Southwest Airlines’s Moving Average

Southwest Airlines’s value is under its 50-day moving average of $42.37 and way below its 200-day moving average of $44.97.

2. DXP Enterprises (DXPE)

20.2% sales growth and 7.78% return on equity

DXP Enterprises, Inc. and its subsidiaries distribute maintenance, repair and operating (MRO), products, equipment, services, and other goods to industrial and energy customers, mainly in the United States.

DXP Enterprises’s sales growth this year is expected to be 22.4% and 12.4% for next year.

Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 1.19B for the twelve trailing months.

Volume

Today’s last reported volume for DXP Enterprises is 82437 which is 18.6% below its average volume of 101280.

DXP Enterprises’s sales growth for the next quarter is 20.2%. The company’s growth estimates for the present quarter and the next is 67.5% and 91.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.78%.

Volatility

DXP Enterprises’s last day, last week, and last month’s current intraday variation average was 2.37%, 1.59%, and 1.85%, respectively.

DXP Enterprises’s highest amplitude of average volatility was 3.46% (day), 3.32% (last week), and 3.60% (last month), respectively.

DXP Enterprises’s Stock Yearly Top and Bottom Value

DXP Enterprises’s stock is valued at $33.18 at 20:22 EST, under its 52-week high of $36.26 and way higher than its 52-week low of $22.09.

DXP Enterprises’s Moving Average

DXP Enterprises’s worth is higher than its 50-day moving average of $30.23 and way above its 200-day moving average of $28.89.

3. Surgery Partners (SGRY)

14.1% sales growth and 5.17% return on equity

Surgery Partners, Inc., via its subsidiaries, operates a network in America of surgical facilities as well as ancillary services.

Surgery Partners’s sales growth this year is expected to be 14.7% and 11.7% for next year.

Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 2.38B for the twelve trailing months.

Volume

Today’s last reported volume for Surgery Partners is 228165 which is 60.97% below its average volume of 584612.

Surgery Partners’s sales growth for the next quarter is 14.1%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.17%.

Volatility

Surgery Partners’s last day, last week, and last month’s current intraday variation average was 2.47%, 2.75%, and 2.91%, respectively.

Surgery Partners’s highest amplitude of average volatility was 7.92% (day), 7.61% (last week), and 6.08% (last month), respectively.

Surgery Partners’s Stock Yearly Top and Bottom Value

Surgery Partners’s stock is valued at $36.90 at 20:22 EST, way below its 52-week high of $63.87 and way higher than its 52-week low of $26.66.

Surgery Partners’s Moving Average

Surgery Partners’s worth is above its 50-day moving average of $34.25 and way below its 200-day moving average of $45.38.

4. EZCORP (EZPW)

7.9% sales growth and 3.04% return on equity

EZCORP, Inc. offers pawn loans throughout the United States as well as Latin America.

EZCORP’s sales growth this year is expected to be 15.7% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 24.1%, now sitting on 772.41M for the twelve trailing months.

Volume

Today’s last reported volume for EZCORP is 297648 which is 9.99% below its average volume of 330701.

EZCORP’s sales growth is a negative 0% for the ongoing quarter and 7.9% for the next. The company’s growth estimates for the current quarter and the next is 266.7% and 9.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.04%.

Volatility

EZCORP’s last day, last week, and last month’s current intraday variation average was 3.69%, 1.46%, and 1.76%, respectively.

EZCORP’s highest amplitude of average volatility was 5.20% (day), 3.27% (last week), and 3.83% (last month), respectively.

EZCORP’s Stock Yearly Top and Bottom Value

EZCORP’s stock is valued at $7.87 at 20:22 EST, way under its 52-week high of $8.80 and way higher than its 52-week low of $5.50.

EZCORP’s Moving Average

EZCORP’s worth is higher than its 50-day moving average of $7.50 and way higher than its 200-day moving average of $7.05.

5. Ameren (AEE)

5.9% sales growth and 10.4% return on equity

Ameren’s sales growth this year is expected to be 6.1% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.

Volume

Today’s last reported volume for Ameren is 511429 which is 65.19% below its average volume of 1469590.

Ameren’s sales growth for the next quarter is 5.9%. The company’s growth estimates for the ongoing quarter and the next is 8.8% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.4%.

Volatility

Ameren’s last day, last week, and last month’s current intraday variation average was 0.45%, 0.53%, and 0.82%, respectively.

Ameren’s highest amplitude of average volatility was 1.14% (day), 2.43% (last week), and 1.86% (last month), respectively.

Ameren’s Stock Yearly Top and Bottom Value

Ameren’s stock is valued at $91.61 at 20:22 EST, higher than its 52-week high of $90.77.

Ameren’s Moving Average

Ameren’s worth is above its 50-day moving average of $84.29 and higher than its 200-day moving average of $83.91.

LEAVE A REPLY

Please enter your comment!
Please enter your name here